✦ LIBER ✦

T-1095, a renal Na+-glucose transporter inhibitor, improves hyperglycemia in streptozotocin-induced diabetic rats

✍ Scribed by Tetsuya Adachi; Koichiro Yasuda; Yoshimasa Okamoto; Nobuyuki Shihara; Akira Oku; Kiichiro Ueta; Kazuyuki Kitamura; Akira Saito; Toshio Iwakura; Yuichiro Yamada; Hideki Yano; Yutaka Seino; Kinsuke Tsuda

Book ID: 117828168
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 287 KB
Volume: 49
Category: Article
ISSN: 1532-8600
DOI: 10.1053/meta.2000.7729

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term treatment with the Na+-glucose

Long-term treatment with the Na+-glucose cotransporter inhibitor T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki Rats

✍ Kiichiro Ueta; Tomomi Ishihara; Yukio Matsumoto; Akira Oku; Masao Nawano; Takuya 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 232 KB

Empagliflozin, a novel potent and select

Empagliflozin, a novel potent and selective SGLT-2 inhibitor, improves glycaemic control alone and in combination with insulin in streptozotocin-induced diabetic rats, a model of type 1 diabetes mellitus

✍ G. Luippold; T. Klein; M. Mark; R. Grempler 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 701 KB

Canagliflozin (CANA), a Sodium Glucose C

Canagliflozin (CANA), a Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor, Improves Glycemia and is Well Tolerated in Type 2 Diabetes Mellitus (T2DM) Subjects With Moderate Renal Impairment

✍ Yale, Jean-Francois; Bakris, George; Xi, Liwen; Figueroa, Kate; Wajs, Ewa; Usisk 📂 Article 📅 2012 🏛 Canadian Diabetes Association 🌐 English ⚖ 79 KB